Signaling and sites of interaction for RX-871024 and sulfonylurea in the stimulation of insulin release

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 4 37-4, 1998, Pages

  Efanov, Alexandre M ^a,b   Zaitsev, Sergei V ^a,b   Efanova, Ioulia B ^a,b   Zhu, Shunsheng ^a   Östenson, Claes Göran ^a   Berggren, Per Olof ^a   Efendić, Suad ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Cytoplasmic free Ca2+ concentration; Insulin secretion; Pancreatic islets

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; GLIBENCLAMIDE; GLUCOSE; IMIDAZOLINE DERIVATIVE; INSULIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; RX 871024; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; EXOCYTOSIS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0031957310     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.4.e751     Document Type: Article

References (27)

1. Aguilar-Bryan, L., C. G. Nichols, S. W. Wechsler, J. P. Clement, A. E. Boyd, G. Gonzalez, H. Herrera-Sosa, K. Nguy, J. Bryan, and D. A. Nelson. Cloning of the β-cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268: 423-426, 1995.
2. Berridge, T. L., J. C. Doxey, and A. G. Roach. Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats. Eur. J. Pharmacol. 213: 213-218, 1992.
3. Bradbury, N. A., T. Jilling, G. Berta, E. J. Sorscher, R. J. Bridges, and K. L. Kirk. Regulation of plasma membrane recycling by CFTR. Science 256: 530-532, 1992.
4. Brown, C. A., S. L. F. Chan, M. R. Stillings, S. A. Smith, and N. G. Morgan. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080. Br. J. Pharmacol. 110: 1017-1022, 1993.
5. Brown, C. A., A. C. Loweth, S. A. Smith, and N. G. Morgan. Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites. Br. J. Pharmacol. 108: 312-317, 1993.
6. Chan, S. L. F. Role of alpha 2-adrenoceptors and imidazoline-binding sites in the control of insulin secretion. Clin. Sci. (Colch.) 85: 671-677, 1993.
7. Flatt, P. R., O. Shibier, J. Szecowka, and P. O. Berggren. New perspectives on the actions of sulphonylureas and hyperglycaemic sulphonamides on the pancreatic β-cell. Diabete & Metab. 20: 157-162, 1994.
8. Eliasson, L., E. Renström, C. Ämmälä, P. O. Berggren, A. M. Bertorello, K. Bokvist, A. Chibalin, J. Deeney, P. R. Flatt, J. Gäbel, J. Gromada, O. Larsson, P. Lindström, C. J. Rhodes, and P. Rorsman. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic β-cells. Science 271: 813-815, 1996.
9. 2+ in pancreatic β-cells. Eur. J. Pharmacol. 298: 279-286, 1996.
10. + channels in mouse B cells. J. Clin. Invest. 89: 1288-1295, 1992.
11. + channels in the control of glucose-induced electrical activity in pancreatic B-cells. Pflugers Arch. 416: 568-572, 1990.
12. Higgins, C. F. The ABC of channel regulation. Cell 82: 693-696, 1995.
13. 2+, cyclic AMP, a phorbol ester and noradrenaline. Biochem. J. 254: 397-403, 1988.
14. Loubatieres, A. L., M. M. Mariani, G. Ribes, H. de Malbose, and J. Chapal. Étude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB419 ou glibenclamide. Diabetologia 5: 1-10, 1969.
15. Olmos, G., R. N. Kulkarni, M. Haque, and J. MacDermot. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and 12 receptors. Eur. J. Pharmacol. 262: 41-48, 1994.
16. Östenson, C. G., A. G. Cattaneo, J. C. Doxey, and S. Efendić. α-Adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats. Am. J. Physiol. 257 (Endocrinol. Metab. 20): E439-E443, 1989.
17. Östenson, C. G., and V. Grill. Differences in long-term effects of L-glutamine and D-glucose on insulin release from rat pancreatic islets. Mol. Cell. Endocrinol. 45: 215-221, 1986.
18. Ozanne, S. E., P. C. Guest, J. C. Hutton, and C. N. Hales. Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells. Diabetologia 38: 277-282, 1995.
19. Pfeiffer, E. F., C. Thum, S. Raptis, W. Beischer, and R. Ziegler. Hypoglycemia in diabetics. Horm. Metab. Res. Suppl. 6: 112-126, 1976.
20. + channels in mouse pancreatic β-cells. Br. J. Pharmacol. 101: 115-120, 1990.
21. Remaury, A., and H. Paris. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites. J. Pharmacol. Exp. Ther. 260: 417-426, 1992.
22. Schulz, A., and A. Hasselblatt. An insulin-releasing property of imidazoline derivatives is not limited to compounds that block α-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 340: 321-327, 1989.
23. Schwanstecher, M., C. Schwanstecher, C. Dickel, F. Chudziak, A. Moshiri, and U. Panten. Location of the sulphonylurea receptor at the cytoplasmic face of the β-cell membrane. Br. J. Pharmacol. 113: 903-911, 1994.
24. Sturgess, N. C., M. L. Ashford, D. L. Cook, and C. N. Hales. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 11: 474-475, 1985.
25. ATP channels and interaction with the exocytotic machinery. Diabetes 45: 1610-1618, 1996.
26. 2+ concentration and insulin secretion as evidenced from measurements in mouse single pancreatic islets. Proc. Natl. Acad. Sci. USA 92: 9712-9716, 1995.
27. + currents in pancreatic B-cells. Naunyn Schmiedebergs Arch. Pharmacol. 337: 225-230, 1988.